Novo Nordisk's new anti-obesity drug spurs high demand

By Alain Thériault | Aug. 14, 2024, 10:58 a.m.

Photo: Unsplash | Diana Polekhina

Insurers are already receiving numerous claims for a new appetite-suppressing drug.

This article is reserved to PRO Level subscribers

Discover the PRO Level
Advertisement
Related topics …